67 related articles for article (PubMed ID: 20478458)
1. Major histocompatibility complex class II transactivator inhibits cysteine-rich 61 expression in osteoblastic cells and its implication in the pathogenesis of periapical lesions.
Lee YL; Lin SK; Hong CY; Wang JS; Yang H; Lai EH; Chen MH; Kok SH
J Endod; 2010 Jun; 36(6):1021-5. PubMed ID: 20478458
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin suppresses osteoblastic expression of Cyr61 and progression of apical periodontitis through enhancement of the transcription factor Forkhead/winged helix box protein O3a.
Lin LD; Lin SK; Chao YL; Kok SH; Hong CY; Hou KL; Lai EH; Yang H; Lee MS; Wang JS
J Endod; 2013 May; 39(5):619-25. PubMed ID: 23611379
[TBL] [Abstract][Full Text] [Related]
3. An extract of green tea, epigallocatechin-3-gallate, reduces periapical lesions by inhibiting cysteine-rich 61 expression in osteoblasts.
Lee YL; Hong CY; Kok SH; Hou KL; Lin YT; Chen MH; Wang CC; Lin SK
J Endod; 2009 Feb; 35(2):206-11. PubMed ID: 19166774
[TBL] [Abstract][Full Text] [Related]
4. Simvastatin as a novel strategy to alleviate periapical lesions.
Lin SK; Kok SH; Lee YL; Hou KL; Lin YT; Chen MH; Wang CC; Hong CY
J Endod; 2009 May; 35(5):657-62. PubMed ID: 19410078
[TBL] [Abstract][Full Text] [Related]
5. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
Broxmeyer HE; Cooper S; Hangoc G; Chang CH
Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
[TBL] [Abstract][Full Text] [Related]
6. Simvastatin inhibits cytokine-stimulated Cyr61 expression in osteoblastic cells: a therapeutic benefit for arthritis.
Kok SH; Hou KL; Hong CY; Wang JS; Liang PC; Chang CC; Hsiao M; Yang H; Lai EH; Lin SK
Arthritis Rheum; 2011 Apr; 63(4):1010-20. PubMed ID: 20191585
[TBL] [Abstract][Full Text] [Related]
7. Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.
Sartoris S; Tosi G; De Lerma Barbaro A; Cestari T; Accolla RS
Eur J Immunol; 1996 Oct; 26(10):2456-60. PubMed ID: 8898960
[TBL] [Abstract][Full Text] [Related]
8. TNF-alpha suppresses IFN-gamma-induced MHC class II expression in HT1080 cells by destabilizing class II trans-activator mRNA.
Han Y; Zhou ZH; Ransohoff RM
J Immunol; 1999 Aug; 163(3):1435-40. PubMed ID: 10415044
[TBL] [Abstract][Full Text] [Related]
9. IL-1 beta inhibits IFN-gamma-induced class II MHC expression by suppressing transcription of the class II transactivator gene.
Rohn W; Tang LP; Dong Y; Benveniste EN
J Immunol; 1999 Jan; 162(2):886-96. PubMed ID: 9916712
[TBL] [Abstract][Full Text] [Related]
10. Epigallocatechin-3-gallate diminishes cytokine-stimulated Cyr61 expression in human osteoblastic cells: a therapeutic potential for arthritis.
Wu PH; Lin SK; Lee BS; Kok SH; Wang JH; Hou KL; Yang H; Lai EH; Wang JS; Hong CY
Rheumatology (Oxford); 2012 Nov; 51(11):1953-65. PubMed ID: 22843790
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of MHC class II molecules in highly metastatic breast cancer cells is mediated by the regulation of the CIITA transcription Implication of CIITA in tumor and metastasis development.
Shi B; Vinyals A; Alia P; Broceño C; Chen F; Adrover M; Gelpi C; Price JE; Fabra A
Int J Biochem Cell Biol; 2006; 38(4):544-62. PubMed ID: 16343978
[TBL] [Abstract][Full Text] [Related]
12. IFN-gamma regulation of the type IV class II transactivator promoter in astrocytes.
Dong Y; Rohn WM; Benveniste EN
J Immunol; 1999 Apr; 162(8):4731-9. PubMed ID: 10202014
[TBL] [Abstract][Full Text] [Related]
13. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N
Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
[TBL] [Abstract][Full Text] [Related]
14. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
Cycon KA; Rimsza LM; Murphy SP
Exp Hematol; 2009 Feb; 37(2):184-194. PubMed ID: 19081173
[TBL] [Abstract][Full Text] [Related]
15. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
Geirsson A; Paliwal I; Lynch RJ; Bothwell AL; Hammond GL
Transplantation; 2003 Jul; 76(2):387-94. PubMed ID: 12883198
[TBL] [Abstract][Full Text] [Related]
16. Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.
Mueller RB; Skapenko A; Grunke M; Wendler J; Stuhlmuller B; Kalden JR; Schulze-Koops H
Arthritis Rheum; 2005 Feb; 52(2):451-60. PubMed ID: 15692975
[TBL] [Abstract][Full Text] [Related]
17. IL-1 alpha and TNF-alpha expression in rat periapical lesions and dental pulp after unilateral sympathectomy.
Bletsa A; Heyeraas KJ; Haug SR; Berggreen E
Neuroimmunomodulation; 2004; 11(6):376-84. PubMed ID: 15467353
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
[TBL] [Abstract][Full Text] [Related]
19. N-terminal destruction signals lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA.
Schnappauf F; Hake SB; Camacho Carvajal MM; Bontron S; Lisowska-Grospierre B; Steimle V
Eur J Immunol; 2003 Aug; 33(8):2337-47. PubMed ID: 12884309
[TBL] [Abstract][Full Text] [Related]
20. Immunolocalization of macrophages and transforming growth factor-beta 1 in induced rat periapical lesions.
Lin SK; Hong CY; Chang HH; Chiang CP; Chen CS; Jeng JH; Kuo MY
J Endod; 2000 Jun; 26(6):335-40. PubMed ID: 11199750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
